Kuvan
Kuvan is a medicine authorised by Swissmedic under authorisation number 58475. The authorisation holder is DRAC AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 October 2009 and the authorisation is valid without a time limit. ATC code A16AX07 places the medicine in the group Other alimentary tract and metabolism products.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Kuvan, Tabletten | B | 12 October 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | A16AX07 | 07.99.0. | B |
| 2 | 120 | Tablette(n) | A16AX07 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Kuvan authorised in Switzerland?
Yes. Kuvan is authorised by Swissmedic under authorisation number 58475, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Kuvan have?
Kuvan is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Kuvan?
The authorisation holder is DRAC AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.